Tuesday, November 5, 2024
HomeTagsKazia

Kazia

Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma

Kazia Therapeutics Limited , an oncology-focused drug development company, is pleased to announce positive final data from a phase II clinical study of paxalisib...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics